搜尋





搜尋





市場行情
/
股票
/
aqst
/

Aquestive Therapeutics Inc

AQST

添加自選

3.695USD

-0.025-0.67%

收盤 07-31 16:00（美東）報價延遲15分鐘

463.60M總市值

虧損本益比TTM

Aquestive Therapeutics Inc

3.695

-0.025-0.67%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

AQST 利潤表

您可以在這裡找到Aquestive Therapeutics Inc的年度或季度收入報告，以深入了解Aquestive Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

營業總收入

65.67%14.45M

9.67%13.02M

-5.43%12.81M

-50.23%10.00M

-27.65%8.72M

-10.14%11.87M

4.15%13.54M

51.79%20.10M

8.25%12.05M

23.63%13.21M

13.43%13.00M

-0.18%13.24M

-9.26%11.13M

-3.57%10.68M

-13.73%11.46M

-13.55%13.27M

10.32%12.27M

54.96%11.08M

60.86%13.29M

-29.20%15.35M

26.89%11.12M

-56.46%7.15M

-33.48%8.26M

94.76%21.68M

-30.67%8.77M

-2.41%16.42M

-6.40%12.42M

-20.10%11.13M

-46.00%12.64M

37.96%16.82M

-51.13%13.27M

25.00%13.93M

42.44%23.41M

--12.20M

--27.15M

--11.14M

--16.44M

營業收入

17.05%8.79M

11.34%11.98M

5.32%11.47M

8.16%8.79M

-28.58%7.51M

-2.15%10.76M

-4.57%10.89M

-30.19%8.12M

7.74%10.52M

15.63%11.00M

6.71%11.41M

-6.70%11.64M

-14.07%9.76M

-9.25%9.51M

-14.02%10.69M

-0.84%12.47M

36.50%11.36M

64.21%10.48M

63.83%12.44M

48.31%12.58M

3.06%8.32M

-56.53%6.38M

-24.01%7.59M

-12.44%8.48M

11.38%8.08M

76.93%14.68M

10.93%9.99M

11.54%9.69M

-37.28%7.25M

-21.58%8.30M

-0.17%9.01M

-15.98%8.68M

13.84%11.56M

--10.58M

--9.02M

--10.34M

--10.15M

主營業務成本

-5.01%3.47M

29.12%5.84M

1.56%4.51M

0.77%4.56M

-16.79%3.65M

-3.40%4.52M

-7.52%4.44M

-31.60%4.53M

-7.35%4.39M

-11.80%4.68M

3.74%4.80M

26.23%6.62M

12.41%4.74M

57.61%5.30M

5.11%4.63M

17.38%5.24M

52.85%4.21M

20.73%3.37M

47.75%4.40M

26.19%4.47M

-24.65%2.76M

-58.95%2.79M

-35.86%2.98M

-34.70%3.54M

4.36%3.66M

41.88%6.79M

-16.97%4.64M

8.99%5.42M

-37.79%3.51M

-14.75%4.79M

14.59%5.59M

-3.27%4.97M

34.70%5.64M

--5.62M

--4.88M

--5.14M

--4.18M

營業費用

-33.59%18.65M

64.48%41.85M

11.24%24.29M

6.62%21.37M

33.67%28.09M

48.66%25.45M

41.96%21.83M

14.87%20.04M

33.49%21.01M

-20.00%17.12M

-24.30%15.38M

-32.95%17.45M

-28.49%15.74M

-5.94%21.39M

-4.42%20.32M

19.05%26.03M

12.02%22.01M

-0.21%22.75M

-3.57%21.25M

2.73%21.86M

-13.17%19.65M

-13.40%22.80M

-5.89%22.04M

-28.63%21.28M

-12.02%22.63M

-9.77%26.32M

4.22%23.42M

-36.03%29.82M

42.04%25.72M

49.98%29.17M

34.36%22.47M

206.65%46.61M

15.66%18.11M

--19.45M

--16.73M

--15.20M

--15.65M

研發費用

-21.58%4.20M

-35.00%3.20M

-14.03%4.53M

-1.37%4.11M

-9.63%5.36M

70.26%4.92M

64.86%5.27M

19.84%4.16M

67.24%5.93M

-32.49%2.89M

-1.11%3.20M

-33.19%3.47M

-25.69%3.55M

-2.77%4.28M

-31.61%3.23M

21.96%5.20M

30.45%4.77M

-0.56%4.40M

-34.90%4.73M

10.79%4.26M

-15.96%3.66M

44.75%4.42M

43.39%7.26M

-52.80%3.85M

1.19%4.35M

-46.21%3.06M

11.67%5.06M

1.96%8.15M

-12.20%4.30M

-9.38%5.68M

-20.23%4.53M

65.27%7.99M

-20.02%4.90M

--6.27M

--5.68M

--4.84M

--6.13M

折舊攤銷及損耗

-18.71%113.00K

-11.56%130.00K

-12.58%139.00K

-31.71%140.00K

-32.85%139.00K

-68.52%147.00K

-39.77%159.00K

-29.07%205.00K

-36.31%207.00K

17.63%467.00K

-55.70%264.00K

-56.67%289.00K

-55.30%325.00K

-45.69%397.00K

-19.13%596.00K

-10.11%667.00K

-3.84%727.00K

-42.80%731.00K

1.38%737.00K

4.21%742.00K

3.99%756.00K

65.12%1.28M

2.54%727.00K

-1.66%712.00K

-2.94%727.00K

1.84%774.00K

-4.96%709.00K

-6.82%724.00K

-21.41%749.00K

-21.41%760.00K

-22.05%746.00K

-18.12%777.00K

2.69%953.00K

--967.00K

--957.00K

--949.00K

--928.00K

營業利潤

78.29%-4.20M

-112.38%-28.84M

-38.47%-11.48M

-20769.09%-11.37M

-116.20%-19.36M

-247.20%-13.58M

-248.76%-8.29M

101.31%55.00K

-94.51%-8.96M

63.49%-3.91M

73.15%-2.38M

67.02%-4.21M

52.71%-4.61M

8.19%-10.71M

-11.11%-8.85M

-95.83%-12.76M

-14.23%-9.74M

25.42%-11.67M

42.18%-7.97M

-1749.87%-6.52M

38.50%-8.53M

-57.98%-15.65M

-25.26%-13.78M

102.11%395.00K

-6.02%-13.86M

19.80%-9.90M

-19.53%-11.00M

42.83%-18.69M

-346.45%-13.07M

-70.19%-12.35M

-188.32%-9.20M

-705.27%-32.69M

579.26%5.30M

---7.26M

--10.42M

---4.06M

--781.00K

淨非營業利息收入（費用）

利息收入

-88.36%83.00K

70.57%1.25M

-68.74%306.00K

50.25%2.10M

116.72%713.00K

344.85%734.00K

-35.34%979.00K

981.40%1.40M

-97.73%329.00K

153.85%165.00K

30180.00%1.51M

303.13%129.00K

--14.51M

-51.85%65.00K

--5.00K

-91.42%32.00K

----

3275.00%135.00K

----

1972.22%373.00K

----

-94.37%4.00K

-94.20%8.00K

-88.24%18.00K

-62.77%102.00K

-77.39%71.00K

-36.11%138.00K

--153.00K

--274.00K

--314.00K

--216.00K

----

--0.00

----

利息費用

6.51%2.96M

2.20%2.84M

2.16%2.84M

0.07%2.78M

-0.07%2.78M

22.26%2.78M

121.34%2.78M

102.40%2.78M

94.01%2.78M

37.76%2.27M

-23.83%1.26M

-16.02%1.37M

-11.47%1.44M

-5.39%1.65M

-41.52%1.65M

-40.70%1.64M

-42.37%1.62M

-36.99%1.74M

1.51%2.82M

0.36%2.76M

1.52%2.81M

-1.25%2.77M

4.75%2.78M

41.82%2.75M

43.87%2.77M

47.37%2.80M

37.20%2.65M

0.52%1.94M

-0.05%1.93M

-3.45%1.90M

-1.88%1.93M

-1.13%1.93M

6.00%1.93M

--1.97M

--1.95M

--1.82M

出售證券收益

34.96%-973.00K

0.83%-1.43M

-1.06%-1.43M

-5.58%-1.50M

-5.65%-1.50M

-50.21%-1.45M

-2432.14%-1.42M

-2474.55%-1.42M

-2623.08%-1.42M

-1681.48%-962.00K

97.25%-56.00K

97.16%-55.00K

97.21%-52.00K

97.07%-54.00K

45.87%-2.04M

44.11%-1.94M

44.18%-1.86M

5.77%-1.84M

---3.77M

---3.47M

---3.33M

---1.96M

----

特殊收入（費用）

----

100.00%0.00

--0.00

100.00%0.00

---1.03M

--0.00

---353.00K

100.00%0.00

----

---13.82M

----

--0.00

100.00%0.00

----

--0.00

-18.95%-4.90M

100.00%0.00

-100.00%0.00

100.00%0.00

---4.12M

-1774.77%-1.86M

265.95%697.00K

---814.00K

--0.00

--111.00K

---420.00K

其他非經營性收入（費用）

----

---7.00K

---1.00K

---21.00K

--24.00K

--0.00

稅前利潤

64.86%-8.06M

-86.65%-31.86M

-34.21%-15.45M

-393.55%-13.55M

-78.75%-22.93M

-113.10%-17.07M

-429.15%-11.51M

50.16%-2.75M

-259.00%-12.83M

35.15%-8.01M

82.65%-2.17M

66.21%-5.51M

161.03%8.07M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.30M

9.90%-13.22M

-42.11%-28.95M

12.06%-14.55M

-429.86%-12.37M

11.24%-14.67M

-61.19%-20.37M

10.11%-16.55M

88.60%-2.33M

-12.25%-16.53M

9.38%-12.64M

-22.44%-18.41M

43.90%-20.47M

-459.26%-14.73M

-38.88%-13.94M

-277.94%-15.04M

-518.84%-36.49M

381.33%4.10M

---10.04M

--8.45M

---5.90M

---1.46M

所得稅

--0.00

100.00%0.00

--0.00

-113.86%-14.00K

100.00%0.00

-100.00%0.00

--0.00

--101.00K

---140.00K

--284.00K

--0.00

除稅後利潤

64.86%-8.06M

-86.81%-31.86M

-34.21%-15.45M

-393.55%-13.55M

-78.75%-22.93M

-110.27%-17.05M

-465.55%-11.51M

52.61%-2.75M

-259.00%-12.83M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.30M

9.90%-13.22M

-42.11%-28.95M

12.06%-14.55M

-429.86%-12.37M

11.24%-14.67M

-61.19%-20.37M

10.11%-16.55M

88.60%-2.33M

-12.25%-16.53M

9.38%-12.64M

-22.44%-18.41M

43.90%-20.47M

-459.26%-14.73M

-38.88%-13.94M

-277.94%-15.04M

-518.84%-36.49M

381.33%4.10M

---10.04M

--8.45M

---5.90M

---1.46M

持續經營利潤

64.86%-8.06M

-86.81%-31.86M

-34.21%-15.45M

-393.55%-13.55M

-78.75%-22.93M

-110.27%-17.05M

-465.55%-11.51M

52.61%-2.75M

-259.00%-12.83M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.30M

9.90%-13.22M

-42.11%-28.95M

12.06%-14.55M

-429.86%-12.37M

11.24%-14.67M

-61.19%-20.37M

10.11%-16.55M

88.60%-2.33M

-12.25%-16.53M

9.38%-12.64M

-22.44%-18.41M

43.90%-20.47M

-459.26%-14.73M

-38.88%-13.94M

-277.94%-15.04M

-518.84%-36.49M

381.33%4.10M

---10.04M

--8.45M

---5.90M

---1.46M

歸属于母公司的淨利潤

64.86%-8.06M

-86.81%-31.86M

-34.21%-15.45M

-393.55%-13.55M

-78.75%-22.93M

-110.27%-17.05M

-465.55%-11.51M

52.61%-2.75M

-259.00%-12.83M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.30M

9.90%-13.22M

-42.11%-28.95M

12.06%-14.55M

-429.86%-12.37M

11.24%-14.67M

-61.19%-20.37M

10.11%-16.55M

88.60%-2.33M

-12.25%-16.53M

9.38%-12.64M

-22.44%-18.41M

43.90%-20.47M

-459.26%-14.73M

-30.73%-13.94M

-292.18%-15.04M

-460.40%-36.49M

298.02%4.10M

---10.67M

--7.83M

---6.51M

---2.07M

優先股派息

----

-100.00%0.00

--626.00K

--615.00K

--613.00K

歸屬普通股東的淨利潤

64.86%-8.06M

-86.81%-31.86M

-34.21%-15.45M

-393.55%-13.55M

-78.75%-22.93M

-110.27%-17.05M

-465.55%-11.51M

52.61%-2.75M

-259.00%-12.83M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.30M

9.90%-13.22M

-42.11%-28.95M

12.06%-14.55M

-429.86%-12.37M

11.24%-14.67M

-61.19%-20.37M

10.11%-16.55M

88.60%-2.33M

-12.25%-16.53M

9.38%-12.64M

-22.44%-18.41M

43.90%-20.47M

-459.26%-14.73M

-30.73%-13.94M

-292.18%-15.04M

-460.40%-36.49M

298.02%4.10M

---10.67M

--7.83M

---6.51M

---2.07M

基本每股收益

72.63%-0.07

-39.54%-0.26

-10.54%-0.14

-351.81%-0.14

-37.79%-0.24

-55.03%-0.19

-301.65%-0.13

70.11%-0.03

-220.16%-0.17

46.84%-0.12

86.59%-0.03

71.84%-0.10

145.49%0.15

68.33%-0.23

36.76%-0.23

-7.47%-0.36

22.72%-0.32

-18.94%-0.72

24.63%-0.37

-380.14%-0.33

16.22%-0.41

-26.03%-0.60

33.07%-0.49

91.52%-0.07

16.53%-0.49

14.70%-0.48

-15.66%-0.74

56.91%-0.82

-452.58%-0.59

-28.66%-0.56

-299.12%-0.64

-615.50%-1.90

298.02%0.17

---0.44

--0.32

---0.27

---0.08

稀釋每股收益

72.63%-0.07

-39.54%-0.26

-10.54%-0.14

-351.81%-0.14

-37.79%-0.24

-55.03%-0.19

-301.65%-0.13

70.11%-0.03

-259.39%-0.17

46.84%-0.12

86.59%-0.03

71.84%-0.10

134.29%0.11

68.33%-0.23

36.76%-0.23

-7.47%-0.36

22.72%-0.32

-18.94%-0.72

24.63%-0.37

-380.14%-0.33

16.22%-0.41

-26.03%-0.60

33.07%-0.49

91.52%-0.07

16.53%-0.49

14.70%-0.48

-15.66%-0.74

56.91%-0.82

-452.58%-0.59

-28.66%-0.56

-299.12%-0.64

-615.50%-1.90

298.02%0.17

---0.44

--0.32

---0.27

---0.08

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Aquestive Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 AQST 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Aquestive Therapeutics Inc 財年末的營收是多少？



Aquestive Therapeutics Inc 2025 財年營收為 44.55M，高於上一財年的 57.56M。

Aquestive Therapeutics Inc 最近一個季度的營收是多少？



Aquestive Therapeutics Inc 最近一個季度的營收為 14.45M，同比增長 65.67%。

Aquestive Therapeutics Inc 全年的淨利潤是多少？



Aquestive Therapeutics Inc 2025 財年淨利潤為 -83.78M。

Aquestive Therapeutics Inc 上一季度的淨利潤是多少？



Aquestive Therapeutics Inc 最近一個季度的淨利潤為 -8.06M。

Aquestive Therapeutics Inc 年度營業利潤是多少？



Aquestive Therapeutics Inc 2025 財年的營業利潤為 -71.05M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。